May 12, 2008
More than 20 top names in international ME/CFS-virus research will convene in Baltimore to share their latest findings June 22-23 - at a conference sponsored by the HHV-6 Foundation, the IACFS/ME (International Association for CFS/ME), CFIDS Association, others. It will immediately follow the International HHV-6 & 7 Conference.
SUMMARY
For full details, see the 12-page conference brochure http://www.hhv-6conference.com/pdfs/HHV6SatBroch08.pdf.
Purpose: To share current evidence for the role of viral infectious agents in at least a subset of Chronic Fatigue Syndrome: covering the molecular biology, pathogenesis, diagnosis, antiviral therapy, prophylaxis of these infections.
Target audience: “Clinicians and scientists who study the role of viruses in chronic fatigue, post-infective fatigue, and central nervous system dysfunction.” Registration: ASAP, at http://www.hhv-6conference.com/satellite & see forms in brochure.
PRESENTATIONS
HHV-6 & CFS
Anthony Komaroff, MD (Harvard Medical School, Boston) - Overview on HHV-6 & CFS
Kazuhiro Kondo MD, PhD (Jikei University School of Medicine, Tokyo) - Identification of novel HHV-6 neurovirulent latent protein that causes mood disorders in CFS, psychosis and HHV-6 encephalopathy
Jose G. Montoya, MD (Stanford University, California) - Antiviral treatment of CFS patients with elevated antibodies to HHV-6 & EBV
CHRONIC EBV & CFS
Barbara Savoldo, MD (Baylor College of Medicine, Houston, Texas) - Chronic EBV, fatigue and immunotherapy by cytotoxic T-cell lymphocyte infusion
Marshall Williams, PhD (Ohio State University) - EBV DUTPase in CFS and sickness behavior
Brigitte Huber, PhD (Tufts University, Boston) - EBV and interferon activation of retrovirus K-18 in CFS
ENTEROVIRUS & CFS
Nora Chapman, PhD (University of Nebraska, Omaha) - Overview of enterovirus infections and diagnostic testing
John Chia, MD (UCLA School of Medicine, California) - Enterovirus infections in CFS
PARVOVIRUS & CFS
Mariko Seishima, MD (Ogaki Municipal Hospital, Japan) - Elevated Parvovirus antibodies and complement in CFS
Dirk Lassner, PhD (Charite-Universitatsmedizin, Berlin) – Could subset of CFS patients in fact have subclinical viral myocarditis?
BORNA VIRUS & CFS
Liv Bode, PhD (Robert Koch Institute, Berlin) - Human Borna virus infections: a possible role in chronic fatigue syndrome?
Keizo Tomonaga, DVM, PhD (Oska Unviersity, Japan) - Borna Virus antibodies in CFS patients vs. controls
IMUNOLOGICAL MARKERS & INFECTION IN CFS
Nancy Klimas, MD (University of Miami, Florida) - Immune markers in viral illness and CFS
POST-VIRAL FATIGUE: PROSPECTIVE STUDIES
Peter White, MD (Queen Mary School of Medicine, London) - Overview on Post-Viral Fatigue
Andrew Lloyd, MD (University of New South Wales, Australia) - Post-viral fatigue after acute infections
Ute Vollmer-Conna, BSc, PhD (University of New South Wales, Australia) - Cytokines in post-viral fatigue
MICROARRAY STUDIES
Jonthan Kerr MD, PhD (St. George’s University of London) - Gene expression subtypes in patients with CFS and ME
Suzanne Vernon PhD (CFIDS Association of America) - Host genetics and viral infection
TWIN STUDIES ON VIRUSES IN CFS
Birgitta Evengard MD, PhD (Umea University, Sweden) - Viral markers in Swedish twins discordant for CFS
CLINICIAN FORUM: TREATING CFS PATIENTS WITH ANTIVIRALS
Dan Peterson, MD (Sierra Nevada Internal Medicine, Incline Village, Nevada) - Antiviral treatment of patients with HHV-6, EBV & Enterovirus: Case reports
Kenny De Meirleir MD, PhD (Himmunitas Foundation, Belgium) - RNaseL activity: correlation to viral infection in CFS and viral infections
Martin Lerner, MD (William Beaumont Hospital, Michigan) - EBV & CMV in CFS and cardiomyopath
|
